More on MRNA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $63.32 |
|
|||
| Open | $64.78 | ||||
| 52 Wk High | $0.52 | ||||
| 52 Wk Low | $0.08 | ||||
| Day High | $65.53 | ||||
| Day Low | $62.91 | ||||
| P/E | N/A | ||||
| EPS | $-3.80 | ||||
| Volume | 3,978,945 | ||||
- Form SCHEDULE 13G Moderna, Inc. Filed by: Capital World Investors
- Form 4 Moderna, Inc. For: Aug 05 Filed by: Bancel Stephane
- Trump Administration Weighs Order On Autism And Vaccines - Bloomberg
- Form SCHEDULE 13G/A Moderna, Inc. Filed by: FMR LLC
- Piper Sandler Reiterates Overweight Rating on Moderna (MRNA) Following FDA Approval of mRNA Flu Vaccine
- FDA approves Moderna's mRNA influenza vaccine for adults 50 and older
- Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA
- Form 144 Moderna, Inc. Filed by: Bancel Stephane
- Moderna begins Phase 1 trial of Bundibugyo ebolavirus vaccine
- Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
Entities mentioned with MRNA
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Options | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
